Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Depreciation & Amortization (CF) (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Depreciation & Amortization (CF) over the past 9 years, most recently at $148000.0 for Q4 2023.

  • For Q4 2023, Depreciation & Amortization (CF) fell 19.74% year-over-year to $148000.0; the TTM value through Dec 2023 reached $641000.0, down 15.99%, while the annual FY2024 figure was $588000.0, 8.27% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2023 was $148000.0 at Corbus Pharmaceuticals Holdings, down from $153000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $320188.0 in Q2 2020 and troughed at $148000.0 in Q4 2023.
  • A 5-year average of $213352.2 and a median of $193901.5 in 2022 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 109.33% in 2020 and later decreased 28.09% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $273274.0 in 2019, then increased by 3.23% to $282099.0 in 2020, then decreased by 26.38% to $207685.0 in 2021, then dropped by 11.21% to $184397.0 in 2022, then decreased by 19.74% to $148000.0 in 2023.
  • Business Quant data shows Depreciation & Amortization (CF) for CRBP at $148000.0 in Q4 2023, $153000.0 in Q3 2023, and $158130.0 in Q2 2023.